Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
Wednesday, July 1, 2009 - 05:21
in Health & Medicine
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in the July 1 issue of Clinical Cancer Research, paves the way for a Phase 1 clinical trial expected to begin in late 2009.
Read the whole article on Physorg
More from Physorg
Related
- Study identifies biomarker that safely monitors tumor response to new brain cancer treatmentWed, 1 Jul 2009, 0:50:29 EDT
- Biomarkers predict brain tumor's response to therapyTue, 23 Jun 2009, 13:42:50 EDT
- Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomesTue, 15 Jul 2008, 6:08:17 EDT
- New criteria for measuring tumor size and progression will help ease workloads in clinical trialsMon, 19 Jan 2009, 22:29:03 EST
- A short and sweet diagnosis for cancer?Thu, 10 Jul 2008, 12:36:15 EDT